Sailong Pharmaceutical Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -51.84% vs 395.65% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 92.02% vs -218.36% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "153.50",
          "val2": "318.70",
          "chgp": "-51.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.00",
          "val2": "-58.00",
          "chgp": "96.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.40",
          "val2": "1.80",
          "chgp": "-22.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.50",
          "val2": "-81.50",
          "chgp": "92.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-13.20%",
          "val2": "-241.70%",
          "chgp": "22.85%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 97.14% vs -15.23% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -268.28% vs -448.42% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "516.90",
          "val2": "262.20",
          "chgp": "97.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.00",
          "val2": "11.70",
          "chgp": "-168.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.50",
          "val2": "6.80",
          "chgp": "10.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-48.10",
          "val2": "-5.50",
          "chgp": "-774.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-121.90",
          "val2": "-33.10",
          "chgp": "-268.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-121.30%",
          "val2": "-85.40%",
          "chgp": "-3.59%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

153.50

318.70

-51.84%

Operating Profit (PBDIT) excl Other Income

-2.00

-58.00

96.55%

Interest

1.40

1.80

-22.22%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-6.50

-81.50

92.02%

Operating Profit Margin (Excl OI)

-13.20%

-241.70%

22.85%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -51.84% vs 395.65% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 92.02% vs -218.36% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

516.90

262.20

97.14%

Operating Profit (PBDIT) excl Other Income

-8.00

11.70

-168.38%

Interest

7.50

6.80

10.29%

Exceptional Items

-48.10

-5.50

-774.55%

Consolidate Net Profit

-121.90

-33.10

-268.28%

Operating Profit Margin (Excl OI)

-121.30%

-85.40%

-3.59%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 97.14% vs -15.23% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -268.28% vs -448.42% in Dec 2024

All Annual Results